newsfilter

Julie

Showing 1–5 of 5 interviews.

  1. Goldman Sachs55 min

    The 2026 Goldman Sachs Analyst Impact Fund Finals

    Asahi Pompei, David Fagenbaum, Gavin McCormick, Julie, Juan Caballero, Richie, Megha, Katharina, Adeline, Zanya, Kai, Helena, Gaspar, Pablo Salame, Julian

    Entering its 11th year, the Goldman Sachs Gives Analyst Impact Fund expanded to include 1,063 analysts who competed for a $500,000 prize pool to fund technology-driven non-profits addressing global challenges. Four finalist organizations were selected for their innovative AI applications: EveryCure secured the $250,000 grand prize for repurposing drugs, while Thorn, BuildChange, and WattTime received funds to combat child sexual abuse material, construct disaster-resilient housing, and index AI data center emissions respectively. This event underscored the firm's strategy of deploying both capital and human expertise through a cross-divisional collaboration that engaged 38 partners as judges and mentees to refine solutions for critical societal issues.

  2. Goldman Sachs57 min

    The 2026 Goldman Sachs Analyst Impact Fund Finals

    Asahi Pompei, David Fagenbaum, Anne Victoire Oriel, Gavin McCormick, Richard Cormack, Julie, Wendy Gorman, Juan Caballero, Jamie Schreiber, Richie, Megha, Katarina, Adeline, Paris, Harshad, Gaspar, Helena, Pablo Salami

    The 11th Annual Goldman Sachs Gives Analyst Impact Fund awarded $500,000 in grants to four non-profits selected by a global panel of junior analysts and Board of Directors judges Ellen Coleman, Michelle Burns, and Kim Harris. Recipients Every Cure, Thorne, Build Change, and WattTime each secured funding to deploy artificial intelligence for repurposing generic drugs, preventing child sexual abuse material, retrofiting disaster-resilient housing, and indexing AI data center emissions. This year's competition engaged 3,000 employees across 60 offices, marking a significant scale-up from the program's inception and resulting in $6 million total donated to 192 non-profits over the fund's decade-long history.

  3. Goldman Sachs57 min

    The 2026 Goldman Sachs Analyst Impact Fund Finals

    Asahi Pompei, David Fagenbaum, Gavin McCormick, Julie, Juan Caballero, Richie, Megha, Katarina, Adeline, Zania, Paris, Harshad, Gaspar, Helena

    The 11th annual Goldman Sachs Gives Analyst Impact Fund convened 1,063 analysts from 60 global offices to award $500,000 to organizations leveraging artificial intelligence for social good. The grand prize of $250,000 went to Every Cure for its AI-driven repurposing of drugs for rare diseases, while Thorn secured the runner-up position to combat AI-generated child exploitation. Judged by board members and senior partners, the competition highlighted a thematic shift where all 18 finalists utilized technology to address critical challenges in health, safety, housing, and climate emissions.

  4. a16z32 min

    Risk-based Contracting for Value-based Care, a Founder's Playbook

    Julie, Justin, Jack Stoddard, Rajay Bhatniji, Corbin Petro, Faye Rottenberg, Satish Jain, Mike Copco, Sunny Goyal, Sonny

    This event analyzes the strategic transition from fee-for-service to value-based care models as a solution to unsustainable healthcare costs and the need for system resiliency. Industry leaders from organizations including Patina, Waymark, and Blue Cross Blue Shield of NC discuss the risk spectrum ranging from pay-for-performance to global capitation, emphasizing that success requires tailored glide paths, early partner alignment, and robust upstream metrics. The presentation outlines critical investment criteria for scaling risk-based contracts, including the necessity for specialized actuarial talent, sufficient capital reserves for statutory requirements, and clear roadmaps for managing total cost of care alongside clinical outcomes.

  5. a16z32 min

    B2C2B in Digital Health, a founder's playbook

    Julie, Jack, Jay, Chris Hogue, Kate, Saji, Jonathan, Amanda, Andrew Lay

    Digital health startups are increasingly adopting a B2C2B motion to bypass traditional enterprise sales bottlenecks by securing direct consumer adoption before targeting senior executives. This dual go-to-market strategy accelerates product-market fit through rapid consumer iteration while generating the usage data required to de-risk large-scale enterprise contracts for investors. Although this approach demands careful resource allocation to balance competing consumer and corporate requirements, it ultimately creates a more defensible business model with faster capital deployment and validated ROI.